UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.18 -2.75 (-3.36%) GOLD FUTURES
2,328.60 +25.70 (+1.12%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,834.58 -1,876.77 (-3.93%)
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.47B |
| Enterprise value | 2.00B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.62 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 2.16 |
| Enterprise value/EBITDA | -7.89 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | -41.98% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 59.84 |
| 52-week low 3 | 17.53 |
| 50-day moving average 3 | 28.34 |
| 200-day moving average 3 | 28.62 |
Share statistics
| Avg vol (3-month) 3 | 903.43k |
| Avg vol (10-day) 3 | 1.32M |
| Shares outstanding 5 | 76.7M |
| Implied shares outstanding 6 | 76.7M |
| Float 8 | 56.57M |
| % held by insiders 1 | 2.37% |
| % held by institutions 1 | 112.61% |
| Shares short (15 Apr 2024) 4 | 10.2M |
| Short ratio (15 Apr 2024) 4 | 14.2 |
| Short % of float (15 Apr 2024) 4 | 17.95% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.32% |
| Shares short (prior month 15 Mar 2024) 4 | 10.89M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -62.45% |
| Operating margin (ttm) | -21.68% |
Management effectiveness
| Return on assets (ttm) | -10.29% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 927.56M |
| Revenue per share (ttm) | 12.28 |
| Quarterly revenue growth (yoy) | -4.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -30.58M |
| Net income avi to common (ttm) | -579.22M |
| Diluted EPS (ttm) | -7.69 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 884.81M |
| Total cash per share (mrq) | 11.54 |
| Total debt (mrq) | 2.26B |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.03 |
| Book value per share (mrq) | -11.66 |
Cash flow statement
| Operating cash flow (ttm) | -58.17M |
| Levered free cash flow (ttm) | 8.31M |
© 2024 Yahoo. All rights reserved.